Suisse Life Science Group is a digital biological intelligence group proudly rooted in Switzerland and headquartered in London.

Technology has the power to help you live healthier.
Our goal is to leverage DNA data and biological sciences to transform health from an expert-driven field – with poor predictive power and large gaps in its fundamental understanding of human biology – into a data-driven predictive science that makes it easy for individuals to take a more active role in managing their health.
Suisse Life Science’s Scienceof[DNA]f(x)™ is the world’s only behavior-change technology based on DNA predispositions that automatically and constantly customizes actionable and results-driven lifestyle recommendations based on the user’s own habits, genes and preferences.

  • Pollution
  • UV exposure
  • Humidity
  • Temperature
  • Stress level
  • Quality sleep time
  • Blood pressure
  • Heart rate
  • Fitness level
  • Food logging
  • Water intake
  • Lifestyle activity logging
  • Body temperature


The big bang is coming in health care, and it will spark the next industrial revolution

The biopharma innovation flow in 2017 was the most exciting the world has seen.
Industrial revolutions occur when there is an unmet need and when different technologies come together to create magic.

The First Industrial Revolution, which spanned the second half of the 18th and the first half of the 19th centuries, occurred by the harnessing of energy (from coal and water power) to replace human or animal labor. The Second Industrial Revolution, in the second half of the 19th century and up until World War I was primarily powered by even “smarter power”: electricity (e.g. telegraph) and hydrocarbons (e.g. internal combustion engine).
Just like electricity and petroleum followed coal and water power to become drivers of the Second Industrial Revolution, the Third Industrial Revolution, which began in the ’80s, was driven by electronics, a “smart derivative” of electricity. Electronics ushered in the personal computer, the internet, fast communication transmissions and lasers. The Fourth Revolution is about networked power at a scale the world has never seen. More than 2 billion people in the world now carry a networked supercomputer (e.g.iPhone or other smartphone) in their pockets.
The Fifth Industrial Revolution will be powered by the coming acceleration in harnessing the biological sciences.
Biology is difficult to characterize, difficult to chart on a systems basis. It is ever changing, difficult to intervene at specific intervention points and can take evasive action when human intervention occurs. Biology is ruled by nature, much more than the laws of physical science or mechanical science.
Some say as much new research is getting added on in the previous two years as the entire period before that. The cost of sequencing a genome has dropped below $1,000, a stunning drop from $2 billion level less than two decades ago. This cost will keep dropping. It is estimated that more than a billion people will soon supply the world’s databases with their genomic and phenotypic information to carry out correlations that educate us about gene variants and their linkage to diseases — and even lifestyles.

This Fifth Revolution, which I predict will start in the next decade, will make this century the Life Sciences Century for Mankind. We will succeed in taming biology and making it into a more predictable science that can be harnessed, similar to the way the previous four industrial revolutions harnessed the physical and mechanical sciences. As the Fifth Industrial revolution unfolds, more and more of us will be living longer and living better.


Consumers are looking for more control over their own health and healthcare, and with the advent of affordable genetic testing there are new avenues for personalized treatment and precision medicine.

DTC genetic testing market is going from $99 million to more than $310 million in 2022.

As consumer tests come to the fore and patients arrive at their doctor appointments brandishing their own genetic data and full of questions and opinions. Concerns still remain that patients – and not a few physicians – don’t always understand what the genetic results mean and just what to do about them. But as consumers get more comfortable with those companies offerings, the visits with their doctors are often getting more complex.

With the increased use of the Internet for medical information, consumers have become medical consumers not just patients This has created a change in the doctor/patient relationship as individuals become more knowledgeable about their own health and want more control over their personal information and treatment decisions. Physicians, meanwhile, are concerned about giving patients too much access to information they may not properly understand. Even many doctors aren’t well-trained in the clinical implications of genetics and genomics.



In the past, patients often gave full autonomy of their health choices and care to their doctors. Now, at-home DNA tests are marketed as holiday gifts during Black Friday, and younger patients are more interested in obtaining information about their own health — and they are more willing to pay for it out of pocket.


“The CMO’s Generation Genome report is focused on the need for the UK to maintain its presence as a world leader in genomic medicine. It presented a vision of genomics being integrated into the NHS within the next 5 years.
The “vast majority” of NHS doctors are “not up to speed” with modern genetic techniques that can transform patients’ chances.

In the short-term it’s the specialists who will use it but we will increasingly see patients knowledgeable about genomics going to their GPs with questions.
In the near future, all doctors will need to be able to understand when to use genomic testing and how to interpret the results they get back from the lab in order to best help their patients.


“Even though the number of genetic counsellors has grown 88% over the last decade— there are currently about 4,200 genetic counsellors in the U.S. — experts say there won’t be an appropriate ratio of counsellor-to-patients until 2023, at the earliest.

China will need at least 100,000 genetic counsellors. “You cannot even find the term for genetic counsellors in the Chinese occupational classification system,” said He Ping, a director at the Genetics Society of China. With the gradual introduction of genetic testing services into clinical practice, the industry began to show a supply shortage.


The world is moving from a disease-centric to a preventive approach to healthcare. With advancements in healthcare from genetics to nutrition, people are becoming more aware of their well-being and lifestyle as a whole, which is a key factor for disease prevention, human performance and healthy aging.
Consumers have an abundant, often overwhelming, choice of products and services aimed at improving their wellbeing, and more and more consumers are choosing to invest in their health. But there’s a problem with the existing ecosystem: Marketers consistently pressure consumers toward the trends they themselves created.
The benefits of personalized approaches are clear, with scientific support that aids in consumer adoption.


The world population is set to increase to nearly 10 billion people in 2050, with an increasing number of people being over the age of 30.
The average lifespan has more than doubled since 1900, and life expectancy currently exceeds 71 years according to the World Health Organization. People are looking toward extending good health and engaging in an array of wellness activities.
Because the population is rapidly growing and aging, the global market for anti-aging products, technologies and services is forecast to grow from $282 billion in 2015 to $331 billion in 2020, as projected by the Global Wellness Institute.


Less than three decades ago, wellness was about solving baseline health and wellness conditions. Now, people are redefining food culture, exercising and wellness as a whole.

More and more, people are concerned with healthy living and aging, which drives demand for various related products.
Nielson’s Global Health and Wellness Report reveals that 50% of people are trying to lose weight, with 72% doing physical exercise and 75% changing their diet.
The global fitness tracker market is set to triple between 2014 and 2019 to more than $5 billion.


While medicine and life science are still rigidly segmented by specialty, scientific age management approaches the problem across disciplines.
As people begin to take self-care more seriously, market opportunities and new wellness sources emerge – superfoods, bio ingredients, nutrition products, high-end cosmetics, exercise methods, “magical” diets and an increasing number of data-driven solutions such as fitness trackers.


Sophisticated customers are following the organic, holistic trend and accepting aging as a natural process. This demographic embraces a cultural shift toward natural aging. They are informed, high-spending customers who desire to preserve their unique selves while aging, taking a progressive, active, drug-free approach.
These are healthy, tech-savvy customers who possess a clear understanding of age management. They see a preventative approach as a whole, not as single products. They have a clear perception of lifestyle as a key factor in their age management.


Consumers are aware of how nutrition affects their health and physical appearance, with 56% of consumers concerned about the impact of their diet on health and appearance.
Bain & Сompany found in a survey that in New York, Munich and New Delhi, 61% of people want to be able to make more personalized choices to stay healthy, while 65% agreed that information should be simple, scientific, integrated and personalized.
Solutions tailored to individuals body and lifestyle require the professional help of external providers, such as specialized clinics – a timely and expensive process. Most personalization efforts are still limited to personalized medicine and mainly focused on cancer cures. But what if we could help helathy people stay healthy, too?

Personalised nutrition and customised nutraceutical supportBespoke skincareAl lifestyle concierge (read time, contextual lifestyle recommendations)Personal wellness coachingNutritionist supportGenomic doctor advice (ON DEMAND)


Technology has fueled the growth of the digital health market, which is projected to grow to more than $230 billion by 2020. Mobile health (mHealth) is forecast to increase almost 10-fold, to $102 billion in 2022 from $11 billion in 2014.


The wearables market has grown immensely over the last decade, but it’s fighting to live up to the hype. Market leaders such as Fitbit and Jawbone are struggling, and data is emerging that wearables could actually be counterproductive when it comes to losing weight. However, there appears to be a bright future for wearables in the healthcare segment.
Platforms that utilize and convert the data generated by wearables into useful, actionable information could prove to be revolutionary. But there is no single, user-friendly platform that provides customers with actionable, data-driven recommendations and products that are uniquely personalized.
Suisse Life Science Group’s unique platform is focused on personalized health that uses various sources of data and converts them into actionable plans for healthy living, disease prevention and age management.


Anti-aging providers increasingly turn to automated technology to give patients access to self-care, regardless of location or health status, enabling providers to care for more patients more efficiently and more economically. With built-in intelligence, this technology can send patients self-management recommendations or other educational content based on their responses to auto-detected data from devices (smartphones and wearables) and self-reported data. The result is a seamless, continuous conversation between patient and provider that engages the patient, informs the provider and leads to better health management overall.


Every two years the world’s database doubles, and every three years health information alone doubles. By 2020, global healthcare data will double every three days – with 80% of the data being unstructured, without a clear relationship. To truly get the results consumers deserve, health and wellness data need to translate into accurate, actionable recommendations for both consumers and professionals.


As patients assume more financial responsibility for sharing the cost of the healthcare services they use, they want (and deserve) to have more control over their experience with providers and insurers. They seek the same high level of service other industries offer, demanding rapid responsiveness to their needs and expecting an easy-to-understand electronic interaction with their service provider. Remote continual care technology accelerates their move from passive patients to proactive, empowered consumers.


According to life science visionary John Nosta, Google and Apple are the next big pharma:

“I wonder if the innovations of Google and Apple are another wake-up call for the life science industry which oftentimes has relied on the snooze function of line extensions and extended-release drugs as the source of income and innovation.”

We’re beyond the days when we’re shocked that a life science innovation doesn’t come from Big Pharma. Yet interestingly, when a Google or Amazon or Apple enters the market with a “significant” innovation, the reaction is more a nod in acknowledgment than a significant surprise. In dramatic contrast to these tech innovations, we find the pharma “big news” headlines are more along the lines of soaring drug costs and executive behavior.
Today’s model of innovation is a far cry from the “molasses hierarchy” of only a few short years ago. And it’s important to point out that much of pharma must be credited for significant advances, including areas like genomics and oncology. And everyone seems to have their accelerator or center of excellence. Yet, in my experience, they are sometimes more a senior management imperative or a check in the box than something that actually moves fast or is focused on excellence.


The healthcare industry isn’t what it used to be. The industry is facing price reductions, declining profits, regulatory pressures and weak patent protection laws. These pressures force pharmaceutical companies to widen their customer base. Furthermore, hospital authorities impose restrictions on medical representatives, limiting face time with healthcare practitioners.
On top of and because of this, there has been a declining appetite among healthcare providers for attending promotional or educational programs organized by pharmaceutical companies.
In the face of this challenge, the industry is casting a hopeful eye toward the digital world.

Digital Spend Across Industries — 2014
Retail: $11.1 billion
Financial Services: $6.2 billion
Automotive: $6.2 billion
Telecommunications: $5.6 billion
CPG: $4.2 billion
Travel: $4.2 billion
Consumer Electronics: $3.8 billion
Media: $2.8 billion
Entertainment: $2.4 billion
Healthcare and Pharma: $1.4 billion
Source: Deloitte


Customizing content for continual, proactive health and wellness

It’s a process of ongoing education, customized pathways, and continual care. First, the patient is introduced to the services available through remote care. Then, when the patient begins to use these tools, providers can automatically tailor pathways to patient needs. With customized content and daily interaction, the patient develops a steady relationship with the provider. The net effect is continuous engagement and greater care efficiency at a much lower cost. Eventually, we move from providing episodic care to delivering truly continual care, with the hands-on care experience reserved for when it’s truly needed.

Curtailing costs and driving revenue
Collecting evidence that it works
Caring for the healthy

If you’re a patient visiting a specific provider organization, whether a physician’s office or a hospital, we want you to walk out with a solution on your phone or tablet that brings you continual care. We want every health care consumer – not only high-risk patients with multiple chronic illnesses but also those who are healthy – to have an ongoing relationship with their provider. Then, when they experience a change in their health status, the connected experience is already in place that will help them achieve the best possible outcomes through continuous provider oversight.

Catalyzing the provider-patient relationship

The increased use of these technologies doesn’t mean hospitals and physician offices are going away. Providers still deliver the initial episode of care that patients trust. Digital health tools serve as relationship extenders, bringing the interaction from the provider setting into the home – or wherever the patient happens to be.